-DOCSTART- -X- O
The -X- _ O
biology -X- _ O
of -X- _ O
autophagy -X- _ B-Patient
in -X- _ O
health -X- _ O
and -X- _ O
disease -X- _ O
conditions -X- _ O
has -X- _ O
been -X- _ O
intensively -X- _ O
analyzed -X- _ O
for -X- _ O
decades. -X- _ O
Several -X- _ O
potential -X- _ O
interventions -X- _ O
can -X- _ O
induce -X- _ O
autophagy -X- _ B-Patient
in -X- _ O
preclinical -X- _ O
research -X- _ O
; -X- _ O
however -X- _ O
, -X- _ O
none -X- _ O
of -X- _ O
these -X- _ O
interventions -X- _ O
are -X- _ O
ready -X- _ O
for -X- _ O
translation -X- _ O
to -X- _ O
clinical -X- _ O
practice -X- _ O
yet. -X- _ O
The -X- _ O
topic -X- _ O
of -X- _ O
the -X- _ O
current -X- _ O
review -X- _ O
is -X- _ O
the -X- _ O
molecular -X- _ O
regulation -X- _ O
of -X- _ O
autophagy -X- _ B-Patient
by -X- _ O
glucagon -X- _ B-Intervention
, -X- _ I-Intervention
glucagon-like -X- _ I-Intervention
peptide -X- _ I-Intervention
( -X- _ I-Intervention
GLP -X- _ I-Intervention
) -X- _ I-Intervention
-1 -X- _ I-Intervention
and -X- _ I-Intervention
the -X- _ I-Intervention
GLP-1-degrading -X- _ I-Intervention
enzyme -X- _ I-Intervention
dipeptidyl -X- _ I-Intervention
peptidase-4 -X- _ I-Intervention
( -X- _ I-Intervention
DPP-4 -X- _ I-Intervention
) -X- _ I-Intervention
. -X- _ O
Glucagon -X- _ B-Outcome
is -X- _ I-Outcome
a -X- _ I-Outcome
well-known -X- _ I-Outcome
polypeptide -X- _ I-Outcome
that -X- _ I-Outcome
induces -X- _ I-Outcome
autophagy. -X- _ I-Outcome
In -X- _ O
contrast -X- _ O
, -X- _ O
GLP-1 -X- _ B-Outcome
has -X- _ I-Outcome
been -X- _ I-Outcome
shown -X- _ I-Outcome
to -X- _ I-Outcome
inhibit -X- _ I-Outcome
glucagon -X- _ I-Outcome
secretion -X- _ I-Outcome
; -X- _ I-Outcome
GLP-1 -X- _ I-Outcome
also -X- _ I-Outcome
has -X- _ I-Outcome
been -X- _ I-Outcome
related -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
induction -X- _ I-Outcome
of -X- _ I-Outcome
autophagy. -X- _ I-Outcome
DPP-4 -X- _ B-Outcome
inhibitors -X- _ I-Outcome
can -X- _ I-Outcome
induce -X- _ I-Outcome
autophagy -X- _ I-Outcome
in -X- _ I-Outcome
a -X- _ I-Outcome
GLP-1â€“dependent -X- _ I-Outcome
manner -X- _ I-Outcome
, -X- _ O
but -X- _ O
other -X- _ O
diverse -X- _ O
effects -X- _ O
could -X- _ O
be -X- _ O
relevant. -X- _ O
Here -X- _ O
, -X- _ O
we -X- _ O
analyze -X- _ O
the -X- _ O
distinct -X- _ O
molecular -X- _ O
regulation -X- _ O
of -X- _ O
autophagy -X- _ B-Patient
by -X- _ O
glucagon -X- _ O
, -X- _ O
GLP-1 -X- _ O
, -X- _ O
and -X- _ O
DPP-4 -X- _ O
inhibitors. -X- _ O
Additionally -X- _ O
, -X- _ O
the -X- _ O
potential -X- _ O
contribution -X- _ O
to -X- _ O
autophagy -X- _ B-Patient
by -X- _ O
glucagon -X- _ O
and -X- _ O
GLP-1 -X- _ O
after -X- _ O
bariatric -X- _ O
surgery -X- _ O
is -X- _ O
discussed -X- _ O
. -X- _ O

